Datametrex Reports Government Clearance To Fulfill Its First COVID-19 Test Kit Order
Each kit contains 288 individual tests, all of which can be completed in one hour.
TORONTO, June 03, 2020 (GLOBE NEWSWIRE) -- Datametrex AI Limited (the "Company" or "Datametrex") (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that its purchaser has received Government clearance to fulfill the purchase order (the “PO”) for COVID-19 test kits for its client, a mining company operational in Mali, West Africa.
Under the terms of the PO, Datametrex will sell to the purchaser an initial 10,000 units of the iONEBIO Inc. iLAMP Novel-CoV19 Detection Kit; 10,000 3 mL Universal Transport Medium (UTM®) Sterile Swabs with 16x100mm Skirted Tubes with Plastic Red Capture Caps, and 1 Real-Time PCR Detection System machine to analyze the samples. The iONEBIO test kits provide results within approximately 15 to 20 minutes with 99.9% accuracy. Each kit contains 288 individual tests, all of which can be completed in one hour.
The total gross sales amount is approximately $500,000 CDN, excluding shipping. The Company has secured all testing kits, swabs, tubes and the PCR machine from the manufacturer required to fulfill the order. Datametrex anticipates that it will have little or no upfront costs associated with the sale of these test kits.
With the Government clearance, the Company is in process of organizing shipping. All of the items will be shipped directly from manufacturers to the purchaser at their operating site in West Africa. Security clearance backlogs continue to streamline as Governments align with the World Health Organization’s remarks on the importance of testing. Governments have urged mining companies to implement testing and screening their workforce to properly fight the virus in order to avoid further closures.
“The opportunity to use advanced COVID-19 testing kits from our partners in Korea to support the diagnostic potential for populations provides an exciting opportunity for countries during this pandemic and the African continent,” says Marshall Gunter, CEO of the Company. "Datametrex is honored to be assisting in the health and welfare of mine employees and local contractors."
According to Africa Centres for Disease Control and Prevention (the “Africa CDC”), there are over 150,000 cases of COVID-19 throughout Africa and with this, Researchers at the African Center of Excellence for Genomics of Infectious Diseases (the “ACEGID”) and other research and public health partners, have announced to implement a Sentinel Project (the “Sentinel”) serveilance protocol for an early warning system in Africa. The Sentinel is the first of eight new projects selected, and it has three pillars: (1) detect, (2) connect and (3) empower. And in the third pillar, the project will empower public health experts by training thousands of healthcare professionals to use the Sentinel tools and deploy the diagnostic technologies for population-level COVID-19 testing, building on previous experiences of ACEGID and the Broad Institute in training over 900 individuals from around the world.
Datametrex’s mission is to provide tools that support companies in fulfilling their operational Health and Safety goals with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain.
About Datametrex
Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com).
Additional information on Datametrex is available at www.datametrex.com
For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]
Neither the TSX Venture Exchange nor it's Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.
Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
